AU7254494A - 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain - Google Patents
5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with painInfo
- Publication number
- AU7254494A AU7254494A AU72544/94A AU7254494A AU7254494A AU 7254494 A AU7254494 A AU 7254494A AU 72544/94 A AU72544/94 A AU 72544/94A AU 7254494 A AU7254494 A AU 7254494A AU 7254494 A AU7254494 A AU 7254494A
- Authority
- AU
- Australia
- Prior art keywords
- antagonists
- pain
- treatment
- disorders associated
- peripheral disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9314174 | 1993-07-08 | ||
GB939314174A GB9314174D0 (en) | 1993-07-08 | 1993-07-08 | 5-ht3-antagonists |
PCT/US1994/007488 WO1995001793A2 (en) | 1993-07-08 | 1994-07-06 | 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7254494A true AU7254494A (en) | 1995-02-06 |
Family
ID=10738511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU72544/94A Abandoned AU7254494A (en) | 1993-07-08 | 1994-07-06 | 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7254494A (en) |
GB (1) | GB9314174D0 (en) |
WO (1) | WO1995001793A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000048581A2 (en) | 1999-02-18 | 2000-08-24 | Novartis Ag | Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases |
EP1419161A1 (en) | 2001-08-24 | 2004-05-19 | PHARMACIA & UPJOHN COMPANY | Substituted-heteroaryl-7-aza 2.2.1]bicycloheptanes for the treatment of disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU611976B2 (en) * | 1987-12-24 | 1991-06-27 | John Wyeth & Brother Limited | Aroyl urea and carbamic acid derivatives of azabicyclo compounds |
GB8922622D0 (en) * | 1989-10-07 | 1989-11-22 | Wyeth John & Brother Ltd | Aroylureas |
GB2236751B (en) * | 1989-10-14 | 1993-04-28 | Wyeth John & Brother Ltd | Heterocyclic compounds |
DE4009565A1 (en) * | 1990-03-24 | 1991-09-26 | Merck Patent Gmbh | INDOLDER DERIVATIVES |
-
1993
- 1993-07-08 GB GB939314174A patent/GB9314174D0/en active Pending
-
1994
- 1994-07-06 WO PCT/US1994/007488 patent/WO1995001793A2/en active Application Filing
- 1994-07-06 AU AU72544/94A patent/AU7254494A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB9314174D0 (en) | 1993-08-18 |
WO1995001793A3 (en) | 1995-03-30 |
WO1995001793A2 (en) | 1995-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL112029A (en) | Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin | |
AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
AU4342997A (en) | Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders | |
AU1173195A (en) | Treatment of immunoregulatory disorders | |
AU6916694A (en) | Novel treatments for allergic diseases | |
AU3459689A (en) | Treatment of skin disorders | |
EP0765663A3 (en) | Use of dienogest for the manufacture of a medicament for the treatment of the skin by topical application | |
AU4131296A (en) | Treatment of disorders with duloxetine | |
AU4530989A (en) | Pharmaceutical composition for the treatment of cerebral edema | |
AU3046897A (en) | Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders | |
AU6241096A (en) | A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders | |
AU1249395A (en) | Topical treatment of ocular photophobia | |
AU5340594A (en) | Skin treatment | |
AU5518694A (en) | Treatment of a group of related disorders | |
AU1727297A (en) | Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse | |
AU4202096A (en) | The use of sertraline to treat cancer patients | |
AU4220193A (en) | Deazaaminopterins for treatment of inflammation | |
AU2068295A (en) | Skin treatment composition | |
AU6147296A (en) | Therapeutic use of acetazolamide for the treatment of brain edema | |
AU7254494A (en) | 5-ht-3-antagonists as topical medicaments for treatment of peripheral disorders associated with pain | |
AU4081393A (en) | Medicaments for the treatment of anxiety | |
AU1727397A (en) | Application of pyrrolidine derivatives to the preparation of medicaments for the treatment of drug abuse | |
IL99236A0 (en) | Pharmaceutical composition for the topical treatment of psoriasis | |
AU7383994A (en) | Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases | |
AU5397994A (en) | Treatment of skin disorders |